What payers require for Zepbound prior authorization Zepbound PA requirements are typically more stringent: Documented BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity Evidence of lifestyle intervention including documented participation in diet, exercise, and behavioral modification programs (usually for at least 3 to 6 months) Prior medication trials (some plans require documented failure of other weight management medications before approving tirzepatide) Specialist involvement (some plans require referral to or management by a bariatric medicine specialist, endocrinologist, or obesity medicine physician) Ongoing weight monitoring documentation with specific weight loss targets (typically 5% of baseline weight within 3 to 6 months of starting therapy) Patients researching BMI requirements for GLP-1 medications should understand that these thresholds directly correspond to the prior authorization criteria their provider must document
Get In Touch With Us Schedule Your Free Consultation Take Your First Step Today Let our team of Medical Professionals help you achieve your body goals
Getting Tri-Immune 1-2 days before travel provides immune support when you need it most
We are committed to providing our patients with innovative and science-based therapies to support healthy, sustainable weight loss and overall metabolic wellness
This kind of proactive care could prevent many cases of infertility or reduce the need for expensive fertility treatments down the line
Valproate has varying effects depending on the stage of brain development, as it can be toxic in embryogenesis (Laegreid et al., 1993) and prenatal valproate in rodents has been used to model autism in rats (Ingram et al., 2000), mice (Yochum et al., 2008) and zebrafish (Li et al., 2024)
